Back to LRVIYLaboratorios Farmaceuticos Rovi, S.A./ADR (LRVIY)View full pipeline
Four different concentrations of Secale cereale allergen extract, positive control and negative control
Phase 2Phase 2
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Allergy to Grass Pollen (Secale Cereale)
View Full LandscapeDrug Information
Target Indication
Allergy to Grass Pollen (Secale Cereale)
Clinical Trial
NCT01408238Last updated: 1/23/2026
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Related Pipeline
Depigoid Parietaria judaica 1000DPP/mlPhase 3
Allergic Rhinoconjunctivitis
Glucosamine and chondroitin sulfate combination (Eurofarma)Phase 3
Osteoarthritis of Knee
Minoxidil Topical FoamPhase 3
Alopecia
Study group - quadrivalent recombinant hemagglutinin influenza vaccinePhase 3
Influenza, Human
Chlorthalidone 25 mg + amiloride hydrochloride 5 mgPhase 3
Arterial Hypertension
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts